Literature DB >> 28304140

Seven years of workplace drug testing in Italy: A systematic review and meta-analysis.

Gian Luca Rosso1,2,3, Cristina Montomoli4, Luca Morini3, Stefano M Candura5.   

Abstract

In Italy, Workplace Drug Testing (WDT) has been compulsory by law for specific categories of workers since 2008, offering the opportunity to compare studies conducted within a single regulatory framework. The aims of this paper are to estimate the overall prevalence of WDT positivity (at screening survey) among Italian workers and evaluate the percentage of true and false positives at confirmation analysis. A systematic review and meta-analysis of the scientific literature on WDT in Italy from January 2008 to March 2015 was carried out, according to the MOOSE guidelines. A random effects model was utilized to calculate pooled prevalence. Potential sources of heterogeneity were explored using sensitivity test and subgroup analysis. The overall meta-analytical prevalence of positivity at WDT among Italian workers was 1.4% [95% confidence interval (CI) = 1.1-1.7%]. It was significantly lower among workers screened with an on-site test (1%; 95% CI = 0.5-1.5%), compared with a bench-top test (1.7%; 95% CI = 1.3-2.1%). Nine studies provided data on false positives at the screening test, with a combined prevalence estimate - calculated on positive cases - of 30% (95% CI = 16-44%). In Italy, the number of true positives at first-level workplace drug testing is low, while the frequency of false positives is relatively high. A revision of the Italian legislation on the subject seems advisable.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  drug testing; false positive; prevalence; review; workers

Mesh:

Year:  2017        PMID: 28304140     DOI: 10.1002/dta.2189

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  6 in total

1.  Methiopropamine and its acute behavioral effects in mice: is there a gray zone in new psychoactive substances users?

Authors:  Fabio De-Giorgio; Sabrine Bilel; Micaela Tirri; Raffaella Arfè; Claudio Trapella; Cristian Camuto; Federica Foti; Paolo Frisoni; Margherita Neri; Francesco Botrè; Matteo Marti
Journal:  Int J Legal Med       Date:  2020-05-01       Impact factor: 2.686

Review 2.  Interpol review of toxicology 2016-2019.

Authors:  Wing-Sum Chan; George Fai Wong; Chi-Wai Hung; Yau-Nga Wong; Kit-Mai Fung; Wai-Kit Lee; Kwok-Leung Dao; Chung-Wing Leung; Kam-Moon Lo; Wing-Man Lee; Bobbie Kwok-Keung Cheung
Journal:  Forensic Sci Int       Date:  2020-05-23       Impact factor: 2.395

3.  Should NPS be included in workplace drug testing?

Authors:  Alberto Salomone; Joseph J Palamar; Marco Vincenti
Journal:  Drug Test Anal       Date:  2020-01-23       Impact factor: 3.345

4.  Occupational Injuries and Use of Benzodiazepines: A Systematic Review and Metanalysis.

Authors:  Sergio Garbarino; Paola Lanteri; Nicola Luigi Bragazzi; Giovanni Gualerzi; Matteo Riccò
Journal:  Front Hum Neurosci       Date:  2021-05-13       Impact factor: 3.169

5.  Point-of-Care diagnostic of SARS-CoV-2: knowledge, attitudes, and perceptions (KAP) of medical workforce in Italy.

Authors:  Matteo Riccò; Pietro Ferraro; Giovanni Gualerzi; Silvia Ranzieri; Nicola Luigi Bragazzi; Federica Balzarini; Carlo Signorelli
Journal:  Acta Biomed       Date:  2020-05-11

6.  Policies and Toxicological Screenings for No Drug Addiction: An Example from the Civil Aviation Workforce.

Authors:  Michele Treglia; Margherita Pallocci; Giorgio Ricciardi-Tenore; Flavio Baretti; Giovanna Bianco; Paola Castellani; Fabrizio Pizzuti; Valeria Ottaviano; Pierluigi Passalacqua; Claudio Leonardi; Luca Coppeta; Agostino Messineo; Roberta Tittarelli
Journal:  Int J Environ Res Public Health       Date:  2022-01-28       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.